http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019052171-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6a6f422b091ba12ea61d4adbf1b0e8e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L2312-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L1-286
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43518
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L26-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-52
filingDate 2018-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e9e13a7b5b20e9458212072736a462d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4836a57ab48bd523c1ce3bd5736c2e78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2edeb7e165047f78b0ed84ef2493c86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6865a0dc8521e24c9d22040ab2b23349
publicationDate 2019-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2019052171-A1
titleOfInvention BIOLOGICAL DAMAGE REPAIR AGENT OR HEMOSTASE AND METHOD THEREOF
abstract The object of the present invention is to provide a lighting control agent and to explore its application, and is intended to improve the tissue binding strength and convenience of the existing biological glue material by providing a new reagent or material for biological damage or hemostasis. In one embodiment, the present invention relates to an agent for repairing biological damage or for hemostasis, the agent comprising a natural biological macromolecule modified by the photoreactive crosslinking group.
priorityDate 2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015138187-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017139318-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20547341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19593367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57310871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229482634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229482632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229482630

Total number of triples: 40.